Table 5 Determinants related to treatment of the child, mentioned by care providers (n = 25)

Treatment (AB) and observation of the child

Procedural clarity (guideline)

4

2

4

2

Logistics observation child at home GBS positive mother without risk factor

N/P

N/P

AB treatment differs between 3 to 5 days treatment

N

N

N

N

AB prophylaxis preterm children not specified

N

N

N

N

Personal benefits/drawbacks (user)

1

0

1

0

Resistance hospital staff admission child and mother after birth

N

N

Outcome expectations (user)

6

4

4

2

40% of cases are missed

N

N

N

N

Increase in yield infection

N

N

AB resistance problem

N

N

Mother or postpartum nursing-aid can adequately observe the child at home of GBS positive mother without risk factor

N/P

N/P

Hospital not always safe for observation child

N

N

N

N

Knowledge (user)

1

1

1

1

Postpartum nursing-aid needs training because of insufficient knowledge

N

N

N

N

Financial resources (organisational context)

1

1

1

1

Increased costs because of culture taking in the child

N

N

N

N

Time available (organisational context)

1

1

1

1

Taking cultures in a child is time consuming

N

N

N

N

Total numbers of determinants, related to

14

9

12

7

the guideline itself

4

2

4

2

the user (care provider)

8

5

6

3

the organisational context

2

2

2

2

the socio-political context

0

0

0

0